Title of article :
Combined androgen blockade may have long term survival benefits over monotherapy, but may increase adverse effects and reduce quality of life in advanced prostate cancer: Abstracted from: Samson DJ, Seidenfeld J, Schmitt B et al. Systematic review and met
Author/Authors :
Akaza، نويسنده , , H، نويسنده ,
